Mitchell Shirvan - 15 Aug 2024 Form 3 Insider Report for Biomotion Sciences (SLXN)

Role
CSO and DO
Signature
/s/ Mirit Horenshtein-Hadar, as attorney for Dr. Mitchell Shirvan
Issuer symbol
SLXN
Transactions as of
15 Aug 2024
Net transactions value
$0
Form type
3
Filing time
15 Aug 2024, 19:49:26 UTC
Next filing
23 Feb 2026
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SLXN Ordinary Shares 132,470 15 Aug 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SLXN Stock Option (right to buy ordinary shares) 15 Aug 2024 Ordinary Shares 64,522 $6.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The subject options to purchase ordinary shares are fully vested and may be exercised right away.

Remarks:

Exhibit 24.1 Power of Attorney